1. Abdi S, Dorranian D, Razavi AE, Naderi GA, Boshtam M, Ghorannevis M. Evaluation of the effects of weak and moderate static magnetic fields on the characteristics of human low density lipoprotein in vitro. Bioelectromagnetics. 2013; 34(5): 397-404.
2. Labreche F, Goldberg MS, Valois MF, Nadon L, Richardson L, Lakhani R, et al. Occupational exposures to extremely low frequency magnetic fields and postmenopausal breast cancer. Am J Ind Med. 2003; 44(6): 643-652.
3. Schüz J, Ahlbom A. Exposure to electromagnetic fields and the risk of childhood leukaemia: a review. Radiat Prot Dosim. 2008; 132(2): 202-211.
4. Xu Y, Wang Y, Yao A, Xu Z, Dou H, Shen S, et al. Low frequency magnetic fields induce autophagy-associated cell death in lung cancer through miR-486-mediated inhibition of Akt/mTOR signaling pathway. Sci Rep. 2017; 7(1): 1-14.
5. Saliev T, Begimbetova D, Masoud AR, Matkarimov B. Biological effects of non-ionizing electromagnetic fields: two sides of a coin. Prog Biophys Mol Biol. 2019; 141: 25-36.
6. Abdi S, Dorranian D, Naderi GA, Razavi AE. Changes in physicochemical charachteristics of human low density lipoprotein nanoparticles by electromagnetic field exposure. Stud U Babes-Bol Che. 2016; 61(1): 185-197.
7. Grassi C, D’Ascenzo M, Torsello A, Martinotti G, Wolf F, Cittadini A, et al. Effects of 50 Hz electromagnetic fields on voltage-gated Ca2+ channels and their role in modulation of neuroendocrine cell proliferation and death. Cell Calcium. 2004; 35(4): 307-315.
8. Phillips JL. Effects of electromagnetic field exposure on gene transcription. J Cell Biochem. 1993; 51(4): 381-386.
9. Vadala M, Vallelunga A, Palmieri L, Palmieri B, Morales-Medina J C, Iannitti T. Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson’s disease. Behav Brain Funct. 2015; 11: 26.
10. Crocetti S, Beyer C, Schade G, Egli M, Frohlich J, Franco-Obregon A. Low intensity and frequency pulsed electromagnetic fields selectively impair breast cancer cell viability. PLoS One. 2013; 8: e72944.
11. Petroulakis E, Mamane Y, Le Bacquer O, Shahbazian D, Sonenberg N. mTOR signaling: implications for cancer and anticancer therapy. Br J Cancer. 2006; 94(2): 195-199.
12. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006; 124(3): 471-484.
13. Patel PH, Chadalavada RS, Chaganti R, Motzer RJ. Targeting von Hippel-Lindau pathway in renal cell carcinoma. Clin Cancer Res. 2006; 12(24): 7215-7220.
14. Yu G, Wang J, Chen Y, Wang X, Pan J, Li G, et al. Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer. Clin Cancer Res. 2009; 15(5): 1821-1829.
15. Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013; 495(7441): 333-338.
16. Hentze MW, Preiss T. Circular RNAs: splicing’s enigma variations. EMBO J. 2013; 32(7): 923-925.
17. Qu S, Yang X, Li X, Wang J, Gao Y, Shang R, et al. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015; 365(2): 141-148.
18. Jiang S, Guo C, Zhang W, Che W, Zhang J, Zhuang S, et al. The integrative regulatory network of circRNA, microRNA and mRNA in atrial fibrillation. Front Genet. 2019; 10: 526.
19. Huang X-Y, Huang Z-L, Xu Y-H, Zheng Q, Chen Z, Song W, et al. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma. Sci Rep. 2017; 7(1): 1-12.
20. Mansoury F, Babaei N, Abdi S, Entezari M, Doosti A. Changes in NOTCH1 gene and its regulatory circRNA, hsa_circ_0005986 expression pattern in human gastric adenocarcinoma and human normal fibroblast cell line following the exposure to extremely low frequency magnetic field. Electromagn Biol Med. 2021; 40(3): 375-383.
21. Bahar M, Majd A, Abdi S. Effects of (ELF) extremely low frequency (50 Hz) AC and DC magnetic fields on lentil germination and seedlings growth. J Theor Appl Phys. 2009; 3(2): 12-16.
22. Mehrara Sh, Mohammadpour H, Miri SR, Abdi S. Plasmacytoma variant translocation 1 and nicotinamide phosphoribosyl-transferase long noncoding RNAs promote colorectal cancer. Gene Rep. 2021; 21: 101-113.
23. Eder SH, Cadiou H, Muhamad A, McNaughton PA, Kirschvink JL, Winklhofer M. Magnetic characterization of isolated candidate vertebrate magnetoreceptor cells. Proc Natl Acad Sci USA. 2012; 109(30): 12022-12027.
24. Zimmerman JW, Pennison MJ, Brezovich I, Yi N, Yang CT, Ramaker R, et al. Cancer cell proliferation is inhibited by specific modulation frequencies. Br J Cancer. 2012; 106(2): 307-313.
25. Ashdown CP, Johns SC, Aminov E, Unanian M, Connacher W, Friend J, et al. Pulsed low-frequency magnetic fields induce tumor membrane disruption and altered cell viability. Biophys J. 2020; 118(7): 1552-1563.
26. Crocetti S, Beyer C, Schade G, Egli M, Fröhlich J, Franco-Obregón A. Low intensity and frequency pulsed electromagnetic fields selectively impair breast cancer cell viability. PLoS One. 2013; 8(9): e72944.
27. Pessina G, Aldinucci C, Palmi M, Sgaragli G, Benocci A, Meini A, et al. Pulsed electromagnetic fields affect the intracellular calcium concentrations in human astrocytoma cells. Bioelectromagnetics. 2001; 22(7): 503-510.
28. Sulpizio M, Falone S, Amicarelli F, Marchisio M, Di Giuseppe F, Eleuterio E, et al. Molecular basis underlying the biological effects elicited by extremely low-frequency magnetic field (ELF-MF) on neuroblastoma cells. J Cell Biochem. 2011; 112(12): 3797-3806.
29. Trillo MÁ, Martínez MA, Cid MA, Leal J, Úbeda A. Influence of a 50 Hz magnetic field and of all-trans‑retinol on the proliferation of human cancer cell lines. Int J Oncol. 2012; 40(5): 1405-1413.
30. Martínez MA, Úbeda A, Cid MA, Trillo MÁ. The proliferative response of NB69 human neuroblastoma cells to a 50 Hz magnetic field is mediated by ERK1/2 signaling. Cell Physiol Biochem. 2012; 29(5-6): 675-686.
31. Huang CY, Chang CW, Chen CR, Chuang CY, Chiang C-S, Shu WY, et al. Extremely low-frequency electromagnetic fields cause G1 phase arrest through the activation of the ATM-Chk2-p21 pathway. PLoS One. 2014; 9(8): e104732.
32. Jung IS, Kim HJ, Noh R, Kim SC, Kim CW. Effects of extremely low frequency magnetic fields on NGF induced neuronal differentiation of PC12 cells. Bioelectromagnetics. 2014; 35(7): 459-469.
33. Litovitz T, Montrose C, Wang W. Dose-response implications of the transient nature of electromagnetic-field-induced bioeffects: Theoretical hypotheses and predictions. Bioelectromagnetics. 1992; 13(S1): 237-246.
34. Feng B, Ye C, Qiu L, Chen L, Fu Y, Sun W. Mitochondrial ROS release and subsequent Akt activation potentially mediated the anti-apoptotic effect of a magnetic field on FL cell. Cell Physiol Biochem. 2016; 38(6): 2489-2499.
35. Robison JG, Pendleton AR, Monson KO, Murray BK, O’Neill KL. Decreased DNA repair rates and protection from heat induced apoptosis mediated by electromagnetic field exposure. Bioelectromagnetics. 2002; 23(2): 106-112.
36. Chiang GG, Abraham RT. Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J Biol Chem. 2005; 280(27): 25485-25490.
37. Huang XY, Huang ZL, Zhang PB, Huang XY, Huang J, Wang HC, et al. CircRNA-100338 is associated with mTOR signaling pathway and poor prognosis in hepatocellular carcinoma. Front Oncol. 2019; 9: 392.
38. Panagopoulos D.J, Karabarbounis A, Margaritis LH. Mechanism for action of electromagnetic fields on cells. Biochem Biophys Res Commun. 2002; 298(1): 95-102.
39. Consales C, Merla C, Marino C, Benassi B. Electromagnetic fields, oxidative stress, and neurodegeneration. Int J Cell Biol. 2012; 1-17.
40. Mihai CT, Rotinberg P, Brinza F, Vochita G. Extremely low-frequency electromagnetic fields cause DNA strand breaks in normal cells. J Environ Health Sci Eng. 2014; 12(1): 15.